Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in September 2026 (Volume 27, Issue 3) Submit Paper

Some aspects of clinical trial of the drug “Vetmicoderm”

Breadcrumb

  • Home
  • Some aspects of clinical trial of the drug “Vetmicoderm”

Ogloblina M. V 1, Bushueva I. V 2, *, Martynyshyn V. P 3, Hunchak V. M 3 and Parchenko V. V 2

1 Petro Mohyla Black Sea National University, Ukraine.
2 Zaporizhzhia State Medical and Pharmaceutical University, Ukraine.
3 Stepan Gzhytskyi National University of Veterinary Medicine and Biotechnologie, Ukraine.

Research Article
 
World Journal of Biology Pharmacy and Health Sciences, 2024, 18(02), 001–004.
Article DOI: 10.30574/wjbphs.2024.18.2.0017
DOI url: https://doi.org/10.30574/wjbphs.2024.18.2.0017

Received on 04 December 2023; revised on 19 January 2024; accepted on 22 January 2024

Our aim was to conduct some clinical trials of the drug «Vetmikoderm» and compare its effectiveness with the well-known agent «Triosan». Clinical trials to determine the therapeutic effectiveness of the drug «Vetmikoderm» were carried out at the veterinary clinic «BEST» (Zaporizhzhia) on two groups of dogs, formed by gradual recruitment (based on the owners' referral to the clinic). To determine the etiological factors contributing to the development of dermatosis, we conducted a study of skin microflora. The sensitivity of microorganisms and fungi to the action of the «Vetmikoderm» preparation was determined by the disc-diffusion method. In the process of diagnostic research, including microbiological studies, it was established that conditionally pathogenic microflora from affected areas of dogs' skin was represented by both microorganisms and fungi. At the same time, fungi prevailed in the microbiocenosis of the selected skin samples. It is worth noting that «Vetmikoderm» has a better fungicidal effect, while «Triosan» is evidently more effective in treating dermatoses with predominantly microbial contamination. It has been proven that the combined use of both drugs has a better influence on the recovery process in animals.

1,2,4-triazoles; Skin diseases of fungal etiology; Sensitivity of microorganisms; Fungi; Clinical studies; Vetmikoderm; Triosan

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2024-0017.pdf

Preview Article PDF

Ogloblina M. V, Bushueva I. V, Martynyshyn V. P, Hunchak V. M and Parchenko V. V. Some aspects of clinical trial of the drug “Vetmicoderm”. World Journal of Biology Pharmacy and Health Sciences, 2024, 18(02), 001–004. Article DOI: https://doi.org/10.30574/wjbphs.2024.18.2.0017

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution